"Sanford North Fargo Clinic in Fargo, ND provides primary care for individuals and families, close to NDSU, downtown Fargo and Sanford Broadway Medical Center."

During the past decade, Sanford Clinic North-Fargo conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 73 clinical trials were completed, i.e. on average, 208.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 44 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanford Clinic North-Fargo" #1 sponsor was "National Cancer Institute (NCI)" with 49 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "Gynecologic Oncology Group" with 7 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanford Clinic North-Fargo" #1 collaborator was "National Cancer Institute (NCI)" with 51 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Sanford Clinic North-Fargo" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Ovarian Carcinoma" (6 trials), "Breast Cancer" (5 trials) and "Recurrent Breast Carcinoma" (5 trials). Many other conditions were trialed in "Sanford Clinic North-Fargo" in a lesser frequency.

Most popular intervention types in "Sanford Clinic North-Fargo" are "Drug" (87 trials), "Other" (73 trials), "Biological" (39 trials), "Procedure" (14 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (24 trials), "Paclitaxel" (17 trials), "Carboplatin" (14 trials) and "Bevacizumab" (10 trials). Other intervention names were less common.

The vast majority of trials in "Sanford Clinic North-Fargo" are 77 trials for "All" genders, 20 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Sanford Clinic North-Fargo". undefined are not yet recruiting, 7 are recruiting, 50 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Sanford Clinic North-Fargo, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sanford Clinic North-Fargo, 4 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".